Mark Cuban Cost Plus Drug Company is a company within the Healthcare and Pharmaceuticals category. Mark Cuban Cost Plus Drug Company (MCCPDC) is a transparent pharmaceutical provider that sells generic medications directly to consumers at a fixed markup. By bypassing traditional pharmacy benefit managers and middlemen, the company aims to significantly reduce the cost of prescription drugs.
Mark Cuban Cost Plus Drug Company was founded in 2020 and is headquartered in Dallas, Texas.
Mark Cuban Cost Plus Drug Company is rated Contender on the Optimly Brand Authority Index, a measure of how well AI models can accurately describe the brand. The exact score is locked for unclaimed profiles.
AI narrative accuracy for Mark Cuban Cost Plus Drug Company is Strong. Significant factual deltas detected.
AI models classify Mark Cuban Cost Plus Drug Company as a Challenger. AI names competitors first.
Mark Cuban Cost Plus Drug Company appeared in 6 of 8 sampled buyer-intent queries (75%). The brand dominates queries related to 'cheap generic drugs' and 'Mark Cuban pharmacy,' but has lower visibility in generic queries like 'best source for blood pressure medication' where traditional PBMs and local pharmacies dominate SEO.
The brand is consistently recognized as an ethical, cost-transparent pharmacy. AI reliably identifies its 'Cost + 15%' formula, though it may lag on recent B2B expansions and manufacturing capabilities. Key gap: AI may not reflect the very latest insurance partnerships or the transition from a pure 'cash-pay' model to one that integrates with certain benefit providers.
Of 5 key facts verified about Mark Cuban Cost Plus Drug Company, 4 are well-documented (likely accurate across AI models), 1 have limited sourcing, and 0 are retrieval-dependent and may be inaccurate without live search.
The specific list of available medications and their real-time pricing, which changes frequently based on supply.
Buyers turn to Mark Cuban Cost Plus Drug Company for how to save money on prescription drugs without insurance, Traditional Insurance/PBM Model: Using traditional pharmacy benefit managers (PBMs) and insurance-based retail pharmacies (CVS, Walgreens) where costs are opaque., Status Quo Out-of-Pocket: Continuing to pay high out-of-pocket costs for prescriptions because the alternative (direct-to-consumer) is unknown or perceived as complex., among 3 documented problem areas.
Buyers evaluating Mark Cuban Cost Plus Drug Company typically ask AI models about "cheapest place to buy generic drugs online", "local pharmacy with generic options", "GoodRx / SingleCare: Using discount card services that negotiate lower rates with existing pharmacies but don't control the supply chain.".
Buyers commonly compare Mark Cuban Cost Plus Drug Company with Mark Cuban pharmacy pricing, transparent drug pricing companies, among 2 documented comparison brands.
Mark Cuban Cost Plus Drug Company's main competitors are Amazon Pharmacy Rxpass. According to AI models, these are the brands most frequently named alongside Mark Cuban Cost Plus Drug Company in buyer-intent queries.
Mark Cuban Cost Plus Drug Company's core products are Direct-to-consumer generic prescription medications, pharmacy services, and pharmaceutical manufacturing..
Mark Cuban Cost Plus Drug Company uses Cost-plus (Cost + 15% + fees).
Mark Cuban Cost Plus Drug Company serves Uninsured patients, under-insured patients with high deductibles, and self-insured employers looking to lower pharmacy spend..
Mark Cuban Cost Plus Drug Company A radical transparency model that sells drugs for cost plus a fixed 15% markup, bypassing the complex PBM rebate system.
Brand Authority Index (BAI) tier: Contender (exact score locked for unclaimed brands)
Archetype: Challenger
https://optimly.ai/brand/mark-cuban-cost-plus-drug-company
Last analyzed: April 10, 2026
Founded: 2020 (Launched 2022)
Headquarters: Dallas, Texas, USA